par Messaaoui, Anissa ;Hajselova, Lucia;Tenoutasse, Sylvie
Référence Journal of pediatric endocrinology & metabolism, 34, 10, page (1319-1322)
Publication Publié, 2021-10-01
Article révisé par les pairs
Résumé : Questions are emerging concerning the long-term consequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, as a possible increase in type 1 diabetes. This study aims to describe the prevalence of anti-SARS-CoV-2 antibodies in children developing type 1 diabetes during this pandemic in Belgium.